311 related articles for article (PubMed ID: 26184160)
1. A Review: Proteomics in Nasopharyngeal Carcinoma.
Chen ZT; Liang ZG; Zhu XD
Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
[TBL] [Abstract][Full Text] [Related]
2. Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis.
Li L; Huang S; Zhu X; Zhou Z; Liu Y; Qu S; Guo Y
Cancer Biother Radiopharm; 2013 Jun; 28(5):380-4. PubMed ID: 23464856
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
[TBL] [Abstract][Full Text] [Related]
4. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
Liao QL; Chen XD; Zhao L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
7. Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis.
Tang CE; Tan T; Li C; Chen ZC; Ruan L; Wang HH; Su T; Zhang PF; Xiao ZQ
Oncol Rep; 2010 Aug; 24(2):495-500. PubMed ID: 20596638
[TBL] [Abstract][Full Text] [Related]
8. Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma.
Liu Z; Chen C; Yang H; Zhang Y; Long J; Long X; Fang W
Proteomics; 2012 Nov; 12(22):3416-25. PubMed ID: 22997098
[TBL] [Abstract][Full Text] [Related]
9. HSP70 and mucin 5B: novel protein targets of N,N'-dinitrosopiperazine-induced nasopharyngeal tumorigenesis.
Tang FQ; Duan CJ; Huang DM; Wang WW; Xie CL; Meng JJ; Wang L; Jiang HY; Feng DY; Wu SH; Gu HH; Li MY; Deng FL; Gong ZJ; Zhou H; Xu YH; Tan C; Zhang X; Cao Y
Cancer Sci; 2009 Feb; 100(2):216-24. PubMed ID: 19068094
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
[TBL] [Abstract][Full Text] [Related]
11. [A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma].
Huang XW; Zhou W; Chen J; Chu HQ; Xiao CW; Hua XY; Zhang P; Li HQ; Cui YH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):509-12. PubMed ID: 21924105
[TBL] [Abstract][Full Text] [Related]
12. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics.
Feng XP; Yi H; Li MY; Li XH; Yi B; Zhang PF; Li C; Peng F; Tang CE; Li JL; Chen ZC; Xiao ZQ
Cancer Res; 2010 May; 70(9):3450-62. PubMed ID: 20406978
[TBL] [Abstract][Full Text] [Related]
13. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method.
Peng X; Gong FM; Ren M; Ai P; Wu S; Tang J; Hu X
Anticancer Drugs; 2016 Sep; 27(8):748-55. PubMed ID: 27333594
[TBL] [Abstract][Full Text] [Related]
15. Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
Wu P; Zhang H; Qi L; Tang Q; Tang Y; Xie Z; Lv Y; Zhao S; Jiang W
Oncol Rep; 2012 Apr; 27(4):987-94. PubMed ID: 22160175
[TBL] [Abstract][Full Text] [Related]
16. A reference map of human nasopharyngeal squamous carcinoma proteome.
Li F; Xiao Z; Zhang P; Li J; Li M; Feng X; Guan Y; Chen Z
Int J Oncol; 2007 May; 30(5):1077-88. PubMed ID: 17390009
[TBL] [Abstract][Full Text] [Related]
17. Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics.
Tang CE; Guan YJ; Yi B; Li XH; Liang K; Zou HY; Yi H; Li MY; Zhang PF; Li C; Peng F; Chen ZC; Yao KT; Xiao ZQ
J Proteome Res; 2010 Dec; 9(12):6101-11. PubMed ID: 20882990
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
[TBL] [Abstract][Full Text] [Related]
19. Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology.
Ruan L; Wang GL; Chen Y; Yi H; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
Med Oncol; 2010 Dec; 27(4):1407-14. PubMed ID: 20049563
[TBL] [Abstract][Full Text] [Related]
20. Proteomics-based identification of proteins with altered expression induced by 12-O-tetradecanoylphorbol 13-acetate in nasopharyngeal carcinoma CNE2 cells.
Jiang PZ; Gan M; Huang H; Shen XM; Wang S; Yao KT
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):97-106. PubMed ID: 15685366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
